- Home
- STIM vs TEI Comparison
STIM vs TEI Comparison
Compare STIM & TEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STIM
- TEI
- Stock Information
- Founded
- STIM 2003
- TEI 1993
- Country
- STIM United States
- TEI United States
- Employees
- STIM N/A
- TEI N/A
- Industry
- STIM Medical/Dental Instruments
- TEI Finance Companies
- Sector
- STIM Health Care
- TEI Finance
- Exchange
- STIM Nasdaq
- TEI Nasdaq
- Market Cap
- STIM 232.3M
- TEI 256.9M
- IPO Year
- STIM 2018
- TEI N/A
- Fundamental
- Price
- STIM $3.76
- TEI $5.63
- Analyst Decision
- STIM Buy
- TEI
- Analyst Count
- STIM 4
- TEI 0
- Target Price
- STIM $6.00
- TEI N/A
- AVG Volume (30 Days)
- STIM 885.6K
- TEI 142.4K
- Earning Date
- STIM 05-06-2025
- TEI 01-01-0001
- Dividend Yield
- STIM N/A
- TEI 10.51%
- EPS Growth
- STIM N/A
- TEI N/A
- EPS
- STIM N/A
- TEI N/A
- Revenue
- STIM $89,448,000.00
- TEI N/A
- Revenue This Year
- STIM $104.65
- TEI N/A
- Revenue Next Year
- STIM $10.69
- TEI N/A
- P/E Ratio
- STIM N/A
- TEI N/A
- Revenue Growth
- STIM 22.16
- TEI N/A
- 52 Week Low
- STIM $0.52
- TEI $4.35
- 52 Week High
- STIM $5.92
- TEI $5.39
- Technical
- Relative Strength Index (RSI)
- STIM 39.38
- TEI 63.71
- Support Level
- STIM $3.78
- TEI $5.58
- Resistance Level
- STIM $4.00
- TEI $5.65
- Average True Range (ATR)
- STIM 0.23
- TEI 0.07
- MACD
- STIM -0.05
- TEI 0.01
- Stochastic Oscillator
- STIM 9.09
- TEI 84.82
About STIM Neuronetics Inc.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.
About TEI Templeton Emerging Markets Income Fund Inc.
Templeton Emerging Markets Income Fund is a closed-end fund. It seeks high, current income, with a secondary goal of capital appreciation, by investing, under normal market conditions. The company's investment portfolio includes Foreign Government and Agency Securities; Quasi-Sovereign and Corporate Bonds; Common Stocks and Other Equity Interests, and Short-Term Investments, and Money Market Funds.